Please note: times are subject to change. Please check the syllabus for the most current version of the agenda upon arriving at the summit.
All Times Listed are for the Eastern Standard Time Zone
Friday, February 23, 2024 |
2:00pm |
Registration Open and Set Up |
2:30pm |
Welcome, Introductions, & CE/CME Housekeeping |
2:40pm | (01) Neuroendocrine Cancers » Aman Chauhan, MD – Sylvester Comprehensive Cancer Center |
3:25pm | Gather Lunch |
3:30pm | Buffet Lunch & Non-CE/CME Symposium Presentation Sponsored by: Taiho Oncology – LONSURF® + bevacizumab for the Treatment of 3L Metastatic Colorectal Cancer » Michael Morse, MD |
4:20pm | (02) Colon Cancer » Cathy Eng, MD – Vanderbilt University Medical Center |
4:50pm |
Break – Trivia for Charity in the Exhibit Hall |
5:00pm | (03) Rectal Cancer (Case Based Discussion) » Moderator: Jeremy C. Jones, MD – Division of Hematology and Medical Oncology Mayo Clinic » Kristen Ciombor, MD, MSCI – Vanderbilt University Medical Center » Christopher Aquina, MD, MPH – General Surgery Specialist Advent Health Cancer Institute » Sarah Hoffe, MD – Interim Chair GI Radiation Oncology Moffitt Cancer Center |
6:00pm |
Network Reception in Exhibit Hall |
Saturday, February 24, 2024 |
7:00am |
Check-in & Breakfast Available in Exhibit Hall |
7:50am |
Welcome, Introductions, & CE/CME Housekeeping |
8:00am | (04) Hepatobiliary Cancers: Are We Looking at the Big Picture? » Ghassan K. Abou-Alfa, MD, MBA – Memorial Sloan Kettering Cancer Center |
9:00am | (05) Molecular Testing in GI Oncology » Aaron J. Scott, MD – University of Arizona Cancer Center – Tucson |
9:45am |
(06) Stump the Faculty |
10:00am |
Break – Refreshments in Exhibit Hall |
10:30am |
(07) Pancreatic Cancer: Metastatic » Eileen M. O’Reilly, MD – Memorial Sloan Kettering Cancer Center |
11:30am | (08) Pancreatic Cancer: Perioperative » Philip A. Philip, MD, PhD, FRCP – Wayne State University |
12:00pm |
(09) Stump the Faculty |
12:15pm |
Gather for Lunch |
12:20pm | Buffet Lunch & Non-CE/CME Symposium Presentation Sponsored by: Bristol Myers Squibb – Opdivo plus chemotherapy vs chemotherapy as first-line treatment for advanced gastric, gastroesophageal junction, and esophageal cancers » Ingrid Rivera, Bristol Myers Squibb |
1:10pm |
Dessert Break in Exhibit Hall |
1:35pm |
(10) Hepatocellular Carcinoma » Stacy Stein, MD – Yale School of Medicine |
2:05pm | (11) Biliary Cancer » Milind Javie, MD – The University of Texas MD Anderson Cancer Center |
2:35pm |
(12) Stump the Faculty |
2:50pm |
Break – Refreshments in Exhibit Hall |
3:20pm | (13) Non-Metastatic Esophageal and Gastric Cancer GE Junction Patient Cases – Locally Advanced vs Metastatic » Moderator: Rutika Mehta, MD, MPH – Moffitt Cancer Center » Ravi Shridhar, MD, PhD – AdventHealth » Jose M. Pimiento, MD – Moffitt Cancer Center |
4:20pm |
(14) Metastatic Esophageal and Gastric Cancer » Jason Starr, DO – Mayo Clinic |
4:50pm |
Closing Comments |